{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:25:32Z","timestamp":1761989132408,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jsat.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T03:02:21Z","timestamp":1515121341000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine"],"prefix":"10.1016","volume":"86","author":[{"given":"Ruthanne","family":"Marcus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha J.","family":"Bojko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-5515","authenticated-orcid":false,"given":"Alyona","family":"Mazhnaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iuliia","family":"Makarenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergii","family":"Filippovych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergii","family":"Dvoriak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra A.","family":"Springer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsat.2018.01.003_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13722-015-0034-5","article-title":"Factors associated with willingness to take extended release naltrexone among injection drug users","volume":"10","author":"Ahamad","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2018.01.003_bb0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsat.2015.10.003","article-title":"Extended-release naltrexone: A qualitative analysis of barriers to routine use","volume":"62","author":"Alanis-Hirsch","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.jsat.2018.01.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000423","article-title":"Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for Ukraine","volume":"8","author":"Alistar","year":"2011","journal-title":"PLoS Medicine"},{"issue":"9738","key":"10.1016\/j.jsat.2018.01.003_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"The Lancet"},{"year":"2016","series-title":"Measuring recovery from substance use and mental disorder","author":"Amaro","key":"10.1016\/j.jsat.2018.01.003_bb0025"},{"issue":"3","key":"10.1016\/j.jsat.2018.01.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059643","article-title":"Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community","volume":"8","author":"Azbel","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jsat.2018.01.003_bb0035","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJMp1109283","article-title":"Shared decision making \u2014 The pinnacle of patient-centered care","volume":"366","author":"Barry","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.jsat.2018.01.003_bb0040","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/add.12243","article-title":"At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine","volume":"108","author":"Bojko","year":"2013","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jsat.2018.01.003_bb0045","first-page":"255","article-title":"\u201cBureaucracy & Beliefs\u201d: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine","volume":"22","author":"Bojko","year":"2015","journal-title":"Drugs: Education, Prevention, and Policy"},{"key":"10.1016\/j.jsat.2018.01.003_bb0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2016.03.003","article-title":"The future of opioid agonist therapies in Ukraine: A qualitative assessment of multilevel barriers and ways forward to promote retention in treatment","volume":"66","author":"Bojko","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2018.01.003_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/135910457000100301","article-title":"Back-translation for cross-cultural research","volume":"1","author":"Brislin","year":"1970","journal-title":"Journal of Cross-Cultural Psychology"},{"issue":"4","key":"10.1016\/j.jsat.2018.01.003_bb0060","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.drugpo.2006.12.011","article-title":"HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine\u2014Programme description and policy implications","volume":"18","author":"Bruce","year":"2007","journal-title":"The International Journal on Drug Policy"},{"issue":"5988","key":"10.1016\/j.jsat.2018.01.003_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.329.5988.169","article-title":"Law enforcement and drug treatment: A culture clash","volume":"329","author":"Cohen","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jsat.2018.01.003_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jsat.2015.12.004","article-title":"Predictors of continued use of extended-released naltrexone (XR-NTX) for opioid-dependence: An analysis of heroin and non-heroin opioid users in Los Angeles County","volume":"63","author":"Cousins","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2018.01.003_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugpo.2013.08.004","article-title":"What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010\u20132012? A review of the six highest burden countries","volume":"25","author":"Degenhardt","year":"2014","journal-title":"The International Journal on Drug Policy"},{"year":"2008","series-title":"A consultation on the NHS constitution","author":"Department of Health","key":"10.1016\/j.jsat.2018.01.003_bb0080"},{"issue":"2","key":"10.1016\/j.jsat.2018.01.003_bb0085","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cct.2014.09.002","article-title":"Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community","volume":"39","author":"Di Paola","year":"2014","journal-title":"Contemporary Clinical Trials"},{"author":"Dutta","key":"10.1016\/j.jsat.2018.01.003_bb0090"},{"key":"10.1016\/j.jsat.2018.01.003_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1477-7517-5-23","article-title":"On drug treatment and social control: Russian narcology's great leap backwards","volume":"5","author":"Elovich","year":"2008","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"10.1016\/j.jsat.2018.01.003_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJMoa055255","article-title":"Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence","volume":"355","author":"Fiellin","year":"2006","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2018.01.003_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/a0013420","article-title":"Understanding attitudes toward use of medication in substance abuse treatment: A multilevel approach","volume":"6","author":"Fitzgerald","year":"2009","journal-title":"Psychological Services"},{"key":"10.1016\/j.jsat.2018.01.003_bb0110","series-title":"Improving global drug policy: Comparative perspectives and UNGASS","article-title":"Narcotics and nationalism: Russian drug policies and futures","author":"Galeotti","year":"2016"},{"year":"1967","series-title":"The discovery of grounded theory: Strategies for qualitative research","author":"Glaser","key":"10.1016\/j.jsat.2018.01.003_bb0115"},{"issue":"Sp","key":"10.1016\/j.jsat.2018.01.003_bb0120","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.12927\/hcq.2009.20947","article-title":"Shared decision-making","volume":"12","author":"Godolphin","year":"2009","journal-title":"Healthcare Quarterly"},{"issue":"2","key":"10.1016\/j.jsat.2018.01.003_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1287\/mksc.1040.0057","article-title":"Growing, growing, gone: Cascades, diffusion, and turning points in the product life cycle","volume":"23","author":"Golder","year":"2004","journal-title":"Marketing Science"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2018.01.003_bb0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2012.12.008","article-title":"Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes","volume":"131","author":"Haddad","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2018.01.003_bb0135","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11524-014-9924-1","article-title":"Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers","volume":"92","author":"Haddad","year":"2015","journal-title":"Journal of Urban Health"},{"issue":"1","key":"10.1016\/j.jsat.2018.01.003_bb0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2013.05.018","article-title":"High rates of police detention among recently released HIV-infected prisoners in Ukraine: Implications for health outcomes","volume":"133","author":"Izenberg","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"year":"2016","series-title":"Global AIDS update 2016","author":"Joint United Nations Programme on HIV\/AIDS,UNAIDS","key":"10.1016\/j.jsat.2018.01.003_bb0145"},{"key":"10.1016\/j.jsat.2018.01.003_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g3118","article-title":"Russia's ban on methadone for drug users in Crimea will worsen the HIV\/AIDS epidemic and risk public health","volume":"348","author":"Kazatchkine","year":"2014","journal-title":"BMJ"},{"issue":"Suppl. 3","key":"10.1016\/j.jsat.2018.01.003_bb0155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/hiv.12059","article-title":"Association of injecting drug use and late enrolment in HIV medical care in Odessa Region, Ukraine","volume":"14","author":"Kiriazova","year":"2013","journal-title":"HIV Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2018.01.003_bb0160","first-page":"562","article-title":"Entry, exit, growth, and innovation over the product life cycle","volume":"86","author":"Klepper","year":"1996","journal-title":"The American Economic Review"},{"issue":"9","key":"10.1016\/j.jsat.2018.01.003_bb0165","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1111\/add.12208","article-title":"Injectable extended-release naltrexone (XR-NTX) for opioid dependence: Long-term safety and effectiveness","volume":"108","author":"Krupitsky","year":"2013","journal-title":"Addiction"},{"issue":"9792","key":"10.1016\/j.jsat.2018.01.003_bb0170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(11)61331-7","article-title":"Injectable extended-release naltrexone for opioid dependence","volume":"378","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jsat.2018.01.003_bb0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/YCO.0b013e3283386578","article-title":"Long-acting depot formulations of naltrexone for heroin dependence: A review","volume":"23","author":"Krupitsky","year":"2010","journal-title":"Current Opinion in Psychiatry"},{"issue":"5","key":"10.1016\/j.jsat.2018.01.003_bb0180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11920-010-0135-5","article-title":"Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available","volume":"12","author":"Krupitsky","year":"2010","journal-title":"Current Psychiatry Reports"},{"issue":"4","key":"10.1016\/j.jsat.2018.01.003_bb0185","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsat.2004.02.002","article-title":"Naltrexone for heroin dependence treatment in St. Petersburg, Russia","volume":"26","author":"Krupitsky","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Suppl. 3","key":"10.1016\/j.jsat.2018.01.003_bb0190","article-title":"Factors associated with physical and sexual violence by police among people who inject drugs in Ukraine: Implications for retention on opioid agonist therapy","volume":"19","author":"Kutsa","year":"2016","journal-title":"Journal of the International AIDS Society"},{"issue":"9","key":"10.1016\/j.jsat.2018.01.003_bb0195","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1111\/j.1360-0443.2008.02249.x","article-title":"Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV\/AIDS","volume":"103","author":"Lawrinson","year":"2008","journal-title":"Addiction"},{"issue":"13","key":"10.1016\/j.jsat.2018.01.003_bb0200","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.jsat.2018.01.003_bb0205","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: A pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"issue":"14","key":"10.1016\/j.jsat.2018.01.003_bb0210","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1001\/jama.2010.1427","article-title":"Buprenorphine implants for treatment of opioid dependence: A randomized controlled trial","volume":"304","author":"Ling","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2018.01.003_bb0215","series-title":"Diffusion of technologies and social behavior","first-page":"125","article-title":"New product diffusion models in marketing: A review and directions for research","author":"Mahajan","year":"1991"},{"key":"10.1016\/j.jsat.2018.01.003_bb0220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2017.07.010","article-title":"Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine","volume":"179","author":"Marcus","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2018.01.003_bb0225","series-title":"Evidence-Based Medicine and Narrative Medicine: A Harmonic Couple Narrative Medicine: Bridging the Gap between Evidence-Based Care and Medical Humanities","first-page":"1","author":"Marini","year":"2016"},{"key":"10.1016\/j.jsat.2018.01.003_bb0230","unstructured":"MAXQDA: VERBI Software \u2013 Consult \u2013 Sozialforschung GmbH. (1989\u20132016). MAXQDA. Berlin, Germany."},{"key":"10.1016\/j.jsat.2018.01.003_bb0235","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.17.1.18825","article-title":"The potential for bridging: HIV status awareness and risky sexual behaviour of injection drug users who have non-injecting permanent partners in Ukraine","volume":"17","author":"Mazhnaya","year":"2014","journal-title":"Journal of the International AIDS Society"},{"key":"10.1016\/j.jsat.2018.01.003_bb0240","first-page":"1","article-title":"In their own voices: Breaking the vicious cycle of addiction, treatment and criminal justice among people who inject drugs in Ukraine","author":"Mazhnaya","year":"2016","journal-title":"Drugs: Education, Prevention and Policy"},{"issue":"11","key":"10.1016\/j.jsat.2018.01.003_bb0245","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/09540121003758515","article-title":"\u201cWe fear the police, and the police fear us\u201d: Structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine","volume":"22","author":"Mimiaga","year":"2010","journal-title":"AIDS Care"},{"author":"Oakford","key":"10.1016\/j.jsat.2018.01.003_bb0250"},{"key":"10.1016\/j.jsat.2018.01.003_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001431.pub2","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"3","author":"O'Connor","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"year":"1998","series-title":"Naltrexone and alcoholism treatment 28: Treatment improvement protocol (TIP) series 28","author":"O'Malley","key":"10.1016\/j.jsat.2018.01.003_bb0260"},{"key":"10.1016\/j.jsat.2018.01.003_bb0265","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugpo.2015.12.016","article-title":"Accessing methadone within Moldovan prisons: Prejudice and myths amplified by peers","volume":"29","author":"Polonsky","year":"2016","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2018.01.003_bb0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugalcdep.2014.12.008","article-title":"Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV\/AIDS","volume":"148","author":"Polonsky","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.jsat.2018.01.003_bb0275","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1007\/s10461-016-1375-0","article-title":"Attitudes toward addiction, methadone treatment, and recovery among HIV-infected Ukrainian prisoners who inject drugs: Incarceration effects and exploration of mediators","volume":"20","author":"Polonsky","year":"2016","journal-title":"AIDS and Behavior"},{"issue":"11","key":"10.1016\/j.jsat.2018.01.003_bb0280","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/j.1360-0443.2011.03523.x","article-title":"Russia and human immunodeficiency virus\u2014beyond crime and punishment","volume":"106","author":"Samet","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2018.01.003_bb0285","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2015.10.023","article-title":"Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system","volume":"157","author":"Springer","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2018.01.003_bb0290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cct.2013.12.006","article-title":"Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community","volume":"37","author":"Springer","year":"2014","journal-title":"Contemporary Clinical Trials"},{"issue":"2","key":"10.1016\/j.jsat.2018.01.003_bb0295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5055\/jom.2008.0012","article-title":"A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners","volume":"4","author":"Springer","year":"2008","journal-title":"Journal of Opioid Management"},{"year":"1998","series-title":"Basics of qualitative research: Techniques and procedures for developing grounded theory","author":"Strauss","key":"10.1016\/j.jsat.2018.01.003_bb0300"},{"year":"2010","series-title":"Recovery-oriented Systems of Care Resource Guide","author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.jsat.2018.01.003_bb4000"},{"issue":"1","key":"10.1016\/j.jsat.2018.01.003_bb0305","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2015","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2018.01.003_bb0310","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2016.02.009","article-title":"Patients' beliefs about medications are associated with stated preference for methadone, buprenorphine, naltrexone, or no medication-assisted therapy following inpatient opioid detoxification","volume":"66","author":"Uebelacker","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"year":"2016","series-title":"Global AIDS update","author":"UNAIDS","key":"10.1016\/j.jsat.2018.01.003_bb0315"},{"issue":"22","key":"10.1016\/j.jsat.2018.01.003_bb0320","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies \u2014 Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.jsat.2018.01.003_bb0325","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.brs.0000155479.88200.32","article-title":"Partnership: Doctor and patient: Advocacy for informed choice vs. informed consent","volume":"30","author":"Weinstein","year":"2005","journal-title":"Spine (Phila Pa 1976)"},{"issue":"3","key":"10.1016\/j.jsat.2018.01.003_bb0330","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1377\/hlthaff.26.3.726","article-title":"Informed patient choice: Patient-centered valuing of surgical risks and benefits","volume":"26","author":"Weinstein","year":"2007","journal-title":"Health Aff (Millwood)"},{"issue":"9738","key":"10.1016\/j.jsat.2018.01.003_bb0335","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(10)60832-X","article-title":"Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward","volume":"376","author":"Wolfe","year":"2010","journal-title":"Lancet"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547217303355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547217303355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:47:24Z","timestamp":1760039244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547217303355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":68,"alternative-id":["S0740547217303355"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2018.01.003","relation":{},"ISSN":["0740-5472"],"issn-type":[{"type":"print","value":"0740-5472"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}